- Zenflow secures $52M Series D financing to support commercialization of its Spring System
Zenflow secures $52M Series D financing to support commercialization of its Spring System
- InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
- Purple AI closes Series A, doubles valuation as it targets US stroke AI market
Purple AI closes Series A, doubles valuation as it targets US stroke AI market
- Spiro Robotics earns FDA clearance for image-guided system for tracheal intubation
Spiro Robotics has received FDA 510(k) clearance for Spiro-VISTA, its handheld, dual image-guided robotic system designed to assist with tracheal intubation in adult hospital patients. The Video Intubation System for Total Access (Spiro-VISTA) is indicated for both difficult and routine tracheal int
- Stereotaxis completes $45M Robocath acquisition to strengthen robotic endovascular platform
Stereotaxis has completed its previously announced acquisition of Robocath in a deal valued at up to $45 million, strengthening its position in the endovascular robotics market. The transaction includes an upfront payment of $20 million, with up to $25 million in milestone-based payments tied to reg
- CurifyLabs raises $14M Series A to expand personalized medicine platform
CurifyLabs has raised $14 million in a Series A financing to expand its personalized medicine platform, with proceeds supporting U.S. growth, supply chain expansion, customer support, and product development. The round was co-led by Sandwater and HealthCap, with participation from Tesi and existing
- Jenscare receives CE mark for LuX-Valve Plus tricuspid valve replacement system
Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system, expanding treatment options for patients with severe tricuspid regurgitation. The second-generation device is designed to repla
- Leo Cancer Care raises $65M Series D to scale upright cancer care platform
Leo Cancer Care has raised $65 million in an oversubscribed Series D financing to accelerate the commercialization of its integrated upright cancer care platform across proton therapy, photon therapy, and imaging. The round was led by Yu Galaxy, with participation from new investor Eventide Asset Ma
- Nyra Medical enrolls first patient in mitral valve repair early feasibility study
Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with functional mitral regurgitation (FMR). CARLEN is a single-leaflet implant designed to augment the native mitral valve, res
- AtaCor enrolls first patient in EV-ICD pivotal study with Abbott
AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with Abbott. The investigational system combines AtaCor's Atala parasternal lead with Abbott's E
- Medicaroid receives CE mark for Hinotori surgical robot
Medicaroid has received CE-MDR approval for its Hinotori surgical robot system, enabling the company to expand its robotic-assisted surgery platform into the European market. Hinotori is designed to support minimally invasive surgery with eight-axis robotic arms that replicate surgeons' hand movemen
- xDot Medical can begin FDA IDE study of vascular closure device
xDot Medical has received FDA investigational device exemption (IDE) approval to begin a pivotal clinical trial of its Access Management System (AMS) for closing large-bore femoral arterial and venous access sites following catheter-based procedures. The study will enroll 266 patients, including rol
Market Insight
Evidence-Based Deep Dive
Top Picks
Latest MedTech News
Spiro Robotics has received FDA 510(k) clearance for Spiro-VISTA, its handheld, dual image-guided robotic system designed to assist with tracheal intubation in adult hospital patients.
The Video Intubation System for Total Access (Spiro-VISTA) is indicated for both difficult and routine tracheal intu
Stereotaxis has completed its previously announced acquisition of Robocath in a deal valued at up to $45 million, strengthening its position in the endovascular robotics market.
The transaction includes an upfront payment of $20 million, with up to $25 million in milestone-based payments tied to regu
CurifyLabs has raised $14 million in a Series A financing to expand its personalized medicine platform, with proceeds supporting U.S. growth, supply chain expansion, customer support, and product development.
The round was co-led by Sandwater and HealthCap, with participation from Tesi and existing i
Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system, expanding treatment options for patients with severe tricuspid regurgitation.
The second-generation device is designed to replac
Leo Cancer Care has raised $65 million in an oversubscribed Series D financing to accelerate the commercialization of its integrated upright cancer care platform across proton therapy, photon therapy, and imaging.
The round was led by Yu Galaxy, with participation from new investor Eventide Asset Man
Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with functional mitral regurgitation (FMR).
CARLEN is a single-leaflet implant designed to augment the native mitral valve, rest
AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with Abbott.
The investigational system combines AtaCor's Atala parasternal lead with Abbott's EV
Medicaroid has received CE-MDR approval for its Hinotori surgical robot system, enabling the company to expand its robotic-assisted surgery platform into the European market.
Hinotori is designed to support minimally invasive surgery with eight-axis robotic arms that replicate surgeons' hand movement
xDot Medical has received FDA investigational device exemption (IDE) approval to begin a pivotal clinical trial of its Access Management System (AMS) for closing large-bore femoral arterial and venous access sites following catheter-based procedures.
The study will enroll 266 patients, including roll